Treatments using venlafaxine
AssigneeAmerican Home Products Corporation
InventorsRichard L. Rudolph, Albert T. Derivan, Eric A. Muth, G. Virginia Upton
Life of this patent
Estimating the term…
Loading patent…
AssigneeAmerican Home Products Corporation
InventorsRichard L. Rudolph, Albert T. Derivan, Eric A. Muth, G. Virginia Upton
Estimating the term…
This invention provides a method of treating obesity, generalized anxiety disorder, post-traumatic stress disorder, late luteal phase disphoric disorder (premenstrual syndrome), attention deficit disorder, with and without hyperactivity, Gilles de la Tourette syndrome, bulimia nervosa or Shy Drager Syndrome in a mammal by administering to the mammal an effective amount of a hydroxycycloalkanephenethyl amine of the following structural formula: in which A is a moiety of the formula where the dotted line represents optional unsaturation; R1 is hydrogen or alkyl; R2 is alkyl; R4 is hydrogen, alkyl, formyl, or alkanol; R5 and R6 are, independently, hydrogen, hydroxyl, alkyl, alkoxy, alkanoyloxy, cyano, nitro, alkylmercapto, amino, alkylamino, dialkylamino, alkanamido, halo, trifluoromethyl, or taken together, methylene dioxy; R7 is hydrogen or alkyl; and n is 0, 1, 2, 3, or 4; or a pharmaceutically acceptable salt thereof.
A method of treating panic disorder, in a mammal suffering from panic disorder, comprising administering to the mammal an effective amount of a compound of the formula:
A method of treating panic disorder in a human, comprising administering to the human in need thereof an effective amount of a compound of the formula:
A method of treating panic disorder in a human, the method comprising administering to a human in need thereof a pharmaceutical composition comprising an effective amount of a compound of the formula:
Dependencies are inferred from the claim text.